Inhibrx Biosciences (INBX) News Today $21.06 -0.28 (-1.31%) Closing price 04:00 PM EasternExtended Trading$21.02 -0.04 (-0.19%) As of 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INBX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Inhibrx Biosciences (INBX) Projected to Post Earnings on TuesdayAugust 6 at 10:55 AM | marketbeat.comInhibrx Biosciences Advances HexAgon-HN Study for Head, Neck CancerJuly 29, 2025 | msn.comTabor Asset Management LP Invests $506,000 in Inhibrx Biosciences, Inc. (NASDAQ:INBX)July 22, 2025 | marketbeat.comInhibrx Biosciences: Seeing Soon If The Momentum Is Just HypeJuly 18, 2025 | seekingalpha.comTabor Asset Management LP Takes $506,000 Position in Inhibrx Biosciences, Inc. (NASDAQ:INBX)July 18, 2025 | marketbeat.comNoteworthy Tuesday Option Activity: INBX, ODP, AZO | NasdaqJuly 10, 2025 | nasdaq.comInhibrx Biosciences (NASDAQ:INBX) Shares Up 8.7% - Still a Buy?July 9, 2025 | marketbeat.comINBX - Inhibrx Biosciences Inc Executives - MorningstarJuly 2, 2025 | morningstar.comMInhibrx Biosciences, Inc. (INBX) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comInhibrx Biosciences Inc (INBX) - Investing.comJune 25, 2025 | investing.comNuveen Asset Management LLC Makes New $385,000 Investment in Inhibrx, Inc. (NASDAQ:INBX)June 6, 2025 | marketbeat.comInhibrx, Inc. (NASDAQ:INBX) Shares Sold by Alpha Wealth Funds LLCJune 4, 2025 | marketbeat.comDeutsche Bank AG Takes $302,000 Position in Inhibrx, Inc. (NASDAQ:INBX)June 1, 2025 | marketbeat.comMillennium Management LLC Buys Shares of 258,388 Inhibrx, Inc. (NASDAQ:INBX)May 31, 2025 | marketbeat.comAlpha Wealth Funds LLC Buys New Stake in Inhibrx, Inc. (NASDAQ:INBX)May 29, 2025 | marketbeat.com116,104 Shares in Inhibrx, Inc. (NASDAQ:INBX) Acquired by Northern Trust CorpMay 28, 2025 | marketbeat.comJane Street Group LLC Buys New Shares in Inhibrx, Inc. (NASDAQ:INBX)May 22, 2025 | marketbeat.comSanofi Takes $17.83 Million Position in Inhibrx, Inc. (NASDAQ:INBX)May 19, 2025 | marketbeat.comLaird Norton Wetherby Wealth Management LLC Invests $472,000 in Inhibrx, Inc. (NASDAQ:INBX)May 18, 2025 | marketbeat.comInhibrx Biosciences, Inc.: Inhibrx Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deInhibrx Reports First Quarter 2025 Financial ResultsMay 14, 2025 | prnewswire.comCaption Management LLC Takes $3.08 Million Position in Inhibrx, Inc. (NASDAQ:INBX)May 8, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Makes New Investment in Inhibrx, Inc. (NASDAQ:INBX)May 8, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Purchases Shares of 160,899 Inhibrx, Inc. (NASDAQ:INBX)May 6, 2025 | marketbeat.comBoothbay Fund Management LLC Takes Position in Inhibrx, Inc. (NASDAQ:INBX)May 4, 2025 | marketbeat.comMarshall Wace LLP Takes $825,000 Position in Inhibrx, Inc. (NASDAQ:INBX)May 3, 2025 | marketbeat.comCastalian Partners LLC Purchases Shares of 191,533 Inhibrx, Inc. (NASDAQ:INBX)May 2, 2025 | marketbeat.comGeode Capital Management LLC Invests $3.93 Million in Inhibrx, Inc. (NASDAQ:INBX)April 29, 2025 | marketbeat.comBirchview Capital LP Acquires Shares of 32,110 Inhibrx, Inc. (NASDAQ:INBX)April 28, 2025 | marketbeat.comCredit Industriel ET Commercial Makes New $989,000 Investment in Inhibrx, Inc. (NASDAQ:INBX)April 26, 2025 | marketbeat.comCigogne Management SA Purchases New Holdings in Inhibrx, Inc. (NASDAQ:INBX)April 26, 2025 | marketbeat.com54,345 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Russell Investments Group Ltd.April 23, 2025 | marketbeat.comWalleye Capital LLC Makes New $8.93 Million Investment in Inhibrx, Inc. (NASDAQ:INBX)April 18, 2025 | marketbeat.comKennedy Capital Management LLC Takes $2.55 Million Position in Inhibrx, Inc. (NASDAQ:INBX)April 16, 2025 | marketbeat.comArbiter Partners Capital Management LLC Purchases Shares of 28,095 Inhibrx, Inc. (NASDAQ:INBX)April 10, 2025 | marketbeat.com36,195 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Yakira Capital Management Inc.April 8, 2025 | marketbeat.comRangeley Capital LLC Takes $761,000 Position in Inhibrx, Inc. (NASDAQ:INBX)April 5, 2025 | marketbeat.comSlotnik Capital LLC Acquires New Holdings in Inhibrx, Inc. (NASDAQ:INBX)April 5, 2025 | marketbeat.comInhibrx Biosciences reshuffles leadership, appoints new CSO and PresidentApril 3, 2025 | investing.comCharles Schwab Investment Management Inc. Invests $503,000 in Inhibrx, Inc. (NASDAQ:INBX)April 2, 2025 | marketbeat.comInhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and PresidentApril 1, 2025 | prnewswire.comShort Interest in Inhibrx, Inc. (NASDAQ:INBX) Declines By 19.7%April 1, 2025 | marketbeat.com20,492 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Corient Private Wealth LLCMarch 31, 2025 | marketbeat.com51,445 Shares in Inhibrx, Inc. (NASDAQ:INBX) Purchased by Bank of New York Mellon CorpMarch 26, 2025 | marketbeat.comMeridian Wealth Advisors LLC Buys New Shares in Inhibrx, Inc. (NASDAQ:INBX)March 24, 2025 | marketbeat.comInhibrx Biosciences Full Year 2024 Earnings: Beats ExpectationsMarch 19, 2025 | finance.yahoo.comInhibrx (NASDAQ:INBX) Releases Earnings Results, Misses Expectations By $0.21 EPSMarch 19, 2025 | marketbeat.comInhibrx Biosciences, Inc.: Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 18, 2025 | finanznachrichten.deInhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 17, 2025 | prnewswire.comHighTower Advisors LLC Invests $12.04 Million in Inhibrx, Inc. (NASDAQ:INBX)March 17, 2025 | marketbeat.com Get Inhibrx Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter. Email Address INBX Media Mentions By Week INBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INBX News Sentiment▼0.000.38▲Average Medical News Sentiment INBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INBX Articles This Week▼11▲INBX Articles Average Week Get Inhibrx Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for INBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CureVac News Calliditas Therapeutics AB (publ) News Intellia Therapeutics News Harrow News Praxis Precision Medicines News Avadel Pharmaceuticals News Phibro Animal Health News Pharvaris News Ardelyx News Structure Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INBX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
